Clinical Trial

Learning Amyloid and Tau Results

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This is a prospective, single-cohort, single-center, observational study to assess if learning one's Alzheimer's disease biomarker test result impacts longitudinal psychosocial, behavioral, and neuropsychological outcomes, and to identify factors that moderate and mediate these outcomes. Participants enrolled in this study are requested to complete surveys at four timepoints after learning their Alzheimer's biomarker test results.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Enrolling by Invitation 2026-05-12
Trial Details
NCT Number NCT07222930
Lead Sponsor University of Wisconsin, Madison
Conditions Alzheimer Disease
Enrollment 240 participants
Start Date 2026-02-17
Primary Completion 2029-06 (estimated)
Study Completion 2029-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-24